Voyager Therapeutics (VYGR) Free Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -31.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.46% |
| Dec 31, 2025 | -32.84% |
| Sep 30, 2025 | -23.77% |
| Jun 30, 2025 | -20.71% |
| Mar 31, 2025 | -46.24% |
| Dec 31, 2024 | -49.68% |
| Sep 30, 2024 | -9.72% |
| Jun 30, 2024 | -11.78% |
| Mar 31, 2024 | 67.00% |
| Dec 31, 2023 | 1.35% |
| Sep 30, 2023 | 9.94% |
| Jun 30, 2023 | 55.42% |
| Mar 31, 2023 | 82.32% |
| Dec 31, 2022 | 24.58% |
| Sep 30, 2022 | 4.23% |
| Jun 30, 2022 | 17.44% |
| Mar 31, 2022 | -35.11% |
| Dec 31, 2021 | 36.08% |
| Sep 30, 2021 | -4.93% |
| Jun 30, 2021 | 2.85% |
| Mar 31, 2021 | -34.60% |
| Dec 31, 2020 | -19.41% |
| Sep 30, 2020 | -15.08% |
| Jun 30, 2020 | -19.62% |
| Mar 31, 2020 | -20.69% |
| Dec 31, 2019 | -21.90% |
| Sep 30, 2019 | -20.63% |
| Jun 30, 2019 | -51.87% |
| Mar 31, 2019 | 144.31% |
| Dec 31, 2018 | -29.19% |
| Sep 30, 2018 | -38.19% |
| Jun 30, 2018 | -50.31% |
| Mar 31, 2018 | -8.98% |
| Dec 31, 2017 | -37.24% |